237 related articles for article (PubMed ID: 30085123)
1. ZBTB24 is a transcriptional regulator that coordinates with DNMT3B to control DNA methylation.
Thompson JJ; Kaur R; Sosa CP; Lee JH; Kashiwagi K; Zhou D; Robertson KD
Nucleic Acids Res; 2018 Nov; 46(19):10034-10051. PubMed ID: 30085123
[TBL] [Abstract][Full Text] [Related]
2. Expanding the mutation spectrum in ICF syndrome: Evidence for a gender bias in ICF2.
van den Boogaard ML; Thijssen PE; Aytekin C; Licciardi F; Kıykım AA; Spossito L; Dalm VASH; Driessen GJ; Kersseboom R; de Vries F; van Ostaijen-Ten Dam MM; Ikinciogullari A; Dogu F; Oleastro M; Bailardo E; Daxinger L; Nain E; Baris S; van Tol MJD; Weemaes C; van der Maarel SM
Clin Genet; 2017 Oct; 92(4):380-387. PubMed ID: 28128455
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of specific DNA binding by the transcription factor ZBTB24.
Ren R; Hardikar S; Horton JR; Lu Y; Zeng Y; Singh AK; Lin K; Coletta LD; Shen J; Lin Kong CS; Hashimoto H; Zhang X; Chen T; Cheng X
Nucleic Acids Res; 2019 Sep; 47(16):8388-8398. PubMed ID: 31226215
[TBL] [Abstract][Full Text] [Related]
4. Identification of ZBTB24 protein domains and motifs for heterochromatin localization and transcriptional activation.
Aktar S; Sasaki H; Unoki M
Genes Cells; 2019 Nov; 24(11):746-755. PubMed ID: 31561277
[TBL] [Abstract][Full Text] [Related]
5. Converging disease genes in ICF syndrome: ZBTB24 controls expression of CDCA7 in mammals.
Wu H; Thijssen PE; de Klerk E; Vonk KK; Wang J; den Hamer B; Aytekin C; van der Maarel SM; Daxinger L
Hum Mol Genet; 2016 Sep; 25(18):4041-4051. PubMed ID: 27466202
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation in disease: Immunodeficiency, Centromeric instability, Facial anomalies syndrome.
Vukic M; Daxinger L
Essays Biochem; 2019 Dec; 63(6):773-783. PubMed ID: 31724723
[TBL] [Abstract][Full Text] [Related]
7. Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
de Greef JC; Wang J; Balog J; den Dunnen JT; Frants RR; Straasheijm KR; Aytekin C; van der Burg M; Duprez L; Ferster A; Gennery AR; Gimelli G; Reisli I; Schuetz C; Schulz A; Smeets DFCM; Sznajer Y; Wijmenga C; van Eggermond MC; van Ostaijen-Ten Dam MM; Lankester AC; van Tol MJD; van den Elsen PJ; Weemaes CM; van der Maarel SM
Am J Hum Genet; 2011 Jun; 88(6):796-804. PubMed ID: 21596365
[TBL] [Abstract][Full Text] [Related]
8. Subtelomeric methylation distinguishes between subtypes of Immunodeficiency, Centromeric instability and Facial anomalies syndrome.
Toubiana S; Velasco G; Chityat A; Kaindl AM; Hershtig N; Tzur-Gilat A; Francastel C; Selig S
Hum Mol Genet; 2018 Oct; 27(20):3568-3581. PubMed ID: 30010917
[TBL] [Abstract][Full Text] [Related]
9. Comparative methylome analysis of ICF patients identifies heterochromatin loci that require ZBTB24, CDCA7 and HELLS for their methylated state.
Velasco G; Grillo G; Touleimat N; Ferry L; Ivkovic I; Ribierre F; Deleuze JF; Chantalat S; Picard C; Francastel C
Hum Mol Genet; 2018 Jul; 27(14):2409-2424. PubMed ID: 29659838
[TBL] [Abstract][Full Text] [Related]
10. CDCA7 and HELLS suppress DNA:RNA hybrid-associated DNA damage at pericentromeric repeats.
Unoki M; Sharif J; Saito Y; Velasco G; Francastel C; Koseki H; Sasaki H
Sci Rep; 2020 Oct; 10(1):17865. PubMed ID: 33082427
[TBL] [Abstract][Full Text] [Related]
11. Three novel ZBTB24 mutations identified in Japanese and Cape Verdean type 2 ICF syndrome patients.
Nitta H; Unoki M; Ichiyanagi K; Kosho T; Shigemura T; Takahashi H; Velasco G; Francastel C; Picard C; Kubota T; Sasaki H
J Hum Genet; 2013 Jul; 58(7):455-60. PubMed ID: 23739126
[TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation.
Baubec T; Colombo DF; Wirbelauer C; Schmidt J; Burger L; Krebs AR; Akalin A; Schübeler D
Nature; 2015 Apr; 520(7546):243-7. PubMed ID: 25607372
[TBL] [Abstract][Full Text] [Related]
13. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
15. A novel deletion in ZBTB24 in a Lebanese family with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2.
Chouery E; Abou-Ghoch J; Corbani S; El Ali N; Korban R; Salem N; Castro C; Klayme S; Azoury-Abou Rjeily M; Khoury-Matar R; Debo G; Germanos-Haddad M; Delague V; Lefranc G; Mégarbané A
Clin Genet; 2012 Nov; 82(5):489-93. PubMed ID: 21906047
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Modification Is Regulated by the Interaction of Influenza A Virus Nonstructural Protein 1 with the
Liu S; Liu L; Xu G; Cao Z; Wang Q; Li S; Peng N; Yin J; Yu H; Li M; Xia Z; Zhou L; Lin Y; Wang X; Li Q; Zhu C; Yang X; Wang J; She Y; Lu M; Zhu Y
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651365
[TBL] [Abstract][Full Text] [Related]
17. Enhanced CD19 activity in B cells contributes to immunodeficiency in mice deficient in the ICF syndrome gene Zbtb24.
Ying Z; Hardikar S; Plummer JB; Hamidi T; Liu B; Chen Y; Shen J; Mu Y; McBride KM; Chen T
Cell Mol Immunol; 2023 Dec; 20(12):1487-1498. PubMed ID: 37990035
[TBL] [Abstract][Full Text] [Related]
18. DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions.
Gopalakrishnan S; Sullivan BA; Trazzi S; Della Valle G; Robertson KD
Hum Mol Genet; 2009 Sep; 18(17):3178-93. PubMed ID: 19482874
[TBL] [Abstract][Full Text] [Related]
19. Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
Tao Q; Huang H; Geiman TM; Lim CY; Fu L; Qiu GH; Robertson KD
Hum Mol Genet; 2002 Sep; 11(18):2091-102. PubMed ID: 12189161
[TBL] [Abstract][Full Text] [Related]
20. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
